Skip to main content
Top
Published in: Diabetologia 1/2004

01-01-2004 | Article

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

Authors: A. Gastaldelli, E. Ferrannini, Y. Miyazaki, M. Matsuda, R. A. DeFronzo, MD

Published in: Diabetologia | Issue 1/2004

Login to get access

Abstract

Aims/hypothesis

Both insulin resistance and beta-cell dysfunction play a role in the transition from normal glucose tolerance (NGT) to Type 2 diabetes (T2DM) through impaired glucose tolerance (IGT). The aim of the study was to define the level of glycaemia at which beta-cell dysfunction becomes evident in the context of existing insulin resistance.

Methods

Insulin response (OGTT) and insulin sensitivity (euglycaemic insulin clamp) were evaluated in 388 subjects in the San Antonio Metabolism (SAM) study (138 NGT, 49 IGT and 201 T2DM). In all subjects the insulin secretion/insulin resistance index (ΔI/ΔG÷IR) was calculated as the ratio of the increment in plasma insulin to the increment in plasma glucose during the OGTT divided by insulin resistance, as measured during the clamp.

Results

In lean NGTs with a 2-h plasma glucose concentration (2-h PG) between 5.6 and 6.6 and between 6.7 and 7.7 mmol/l, there was a progressive decline in ΔI/ΔG÷IR compared with NGTs with a 2-h PG less than 5.6 mmol/l. There was a further decline in ΔI/ΔG÷IR in IGTs with a 2-h PG between 7.8 and 9.3 and between 9.4 and 11.0 mmol/l, and in Type 2 diabetic patients with a 2-h PG greater than 11.1 mmol/l. Lean and obese subjects showed coincident patterns of relation of 2-h PG to ΔI/ΔG÷IR.

Conclusion/interpreation

When the plasma insulin response to oral glucose is related to the glycaemic stimulus and severity of insulin resistance, there is a progressive decline in beta-cell function that begins in “normal” glucose tolerant individuals.
Literature
1.
go back to reference DeFronzo RA (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 4:177–269 DeFronzo RA (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 4:177–269
2.
go back to reference Polonsky KS, Sturis J, Bell G (1996) Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777–783CrossRefPubMed Polonsky KS, Sturis J, Bell G (1996) Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777–783CrossRefPubMed
3.
go back to reference Weyer C, Bogardus C, Mott DM et al. (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–94PubMed Weyer C, Bogardus C, Mott DM et al. (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–94PubMed
4.
go back to reference Haffner SM, Stern MP, Mitchell BD et al. (1990) Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283–288PubMed Haffner SM, Stern MP, Mitchell BD et al. (1990) Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283–288PubMed
5.
go back to reference Haffner SM, Miettinen H, Gaskill SP et al. (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican Americans. Diabetes 44:1386–1391PubMed Haffner SM, Miettinen H, Gaskill SP et al. (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican Americans. Diabetes 44:1386–1391PubMed
6.
go back to reference Lillioja S, Mott DM, Howard BV et al. (1988) Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217–1225PubMed Lillioja S, Mott DM, Howard BV et al. (1988) Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217–1225PubMed
7.
go back to reference Dowse GK, Zimmet PZ, Collins VR (1996) Insulin levels and the natural history of glucose intolerance in Nauruans. Diabetes 45:1367–1372PubMed Dowse GK, Zimmet PZ, Collins VR (1996) Insulin levels and the natural history of glucose intolerance in Nauruans. Diabetes 45:1367–1372PubMed
8.
go back to reference Saad MF, Knowler WC, Pettitt D et al. (1989) Sequential changes in serum insulin concentration during development of non-insulin dependent diabetes. Lancet 1:1356–1359CrossRefPubMed Saad MF, Knowler WC, Pettitt D et al. (1989) Sequential changes in serum insulin concentration during development of non-insulin dependent diabetes. Lancet 1:1356–1359CrossRefPubMed
9.
go back to reference Hansen BC, Bodkin NH (1986) Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 29:713–719PubMed Hansen BC, Bodkin NH (1986) Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 29:713–719PubMed
10.
go back to reference Eriksson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343PubMed Eriksson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343PubMed
11.
go back to reference Martin BC, Warram JH, Krolewski AS et al. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925–929PubMed Martin BC, Warram JH, Krolewski AS et al. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925–929PubMed
12.
go back to reference Lillioja S, Nyomba BL, Saad MF et al. (1991) Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 73:866–876PubMed Lillioja S, Nyomba BL, Saad MF et al. (1991) Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 73:866–876PubMed
13.
go back to reference Gulli G, Ferrannini E, Stern M et al. (1992). The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575–1586PubMed Gulli G, Ferrannini E, Stern M et al. (1992). The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575–1586PubMed
14.
go back to reference DeFronzo RA (1988) Lilly Lecture. The triumvirate: beta cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687PubMed DeFronzo RA (1988) Lilly Lecture. The triumvirate: beta cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687PubMed
15.
go back to reference Diamond MP, Thornton K, Connolly-Diamond M et al. (1995) Reciprocal variation in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose tolerance. J Soc Gynecol Invest 2:708–715CrossRef Diamond MP, Thornton K, Connolly-Diamond M et al. (1995) Reciprocal variation in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose tolerance. J Soc Gynecol Invest 2:708–715CrossRef
16.
go back to reference Reaven GM, Hollenbeck CB, Chen YDI (1989) Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52–55PubMed Reaven GM, Hollenbeck CB, Chen YDI (1989) Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52–55PubMed
17.
go back to reference Kahn SE (2001) Clinical review 135. The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047–58 Kahn SE (2001) Clinical review 135. The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047–58
18.
go back to reference Bergman RN, Finegood DT, Kahn SE (2002) The evaluation of β-cell dysfunction and insulin resistance in type 2 diabetes. Europ J Clin Invest 32[Suppl 3]:35–45 Bergman RN, Finegood DT, Kahn SE (2002) The evaluation of β-cell dysfunction and insulin resistance in type 2 diabetes. Europ J Clin Invest 32[Suppl 3]:35–45
19.
go back to reference Saad MF, Knowler WC, Petitt DJ et al. (1988) The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500–1505 Saad MF, Knowler WC, Petitt DJ et al. (1988) The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500–1505
20.
go back to reference Hollenbeck CB, Reaven GM (1987) Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64:1169–1173PubMed Hollenbeck CB, Reaven GM (1987) Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64:1169–1173PubMed
21.
go back to reference Reaven GM (1988) Banting Lecture: Role of insulin resistance in human disease. Diabetes 37:595–607 Reaven GM (1988) Banting Lecture: Role of insulin resistance in human disease. Diabetes 37:595–607
22.
go back to reference Ferrannini E, Natali A, Bell P et al. (1997) Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166–1173PubMed Ferrannini E, Natali A, Bell P et al. (1997) Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166–1173PubMed
23.
go back to reference Efendic S, Grill V, Luft R et al. (1988) Low insulin response: a marker of pre-diabetes. Adv Exp Med Biol 246:167–174PubMed Efendic S, Grill V, Luft R et al. (1988) Low insulin response: a marker of pre-diabetes. Adv Exp Med Biol 246:167–174PubMed
24.
go back to reference Pimenta W, Korytkowski M, Mitrakou A et al. (1995) Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerance individuals with a first degree NIDDM relative. JAMA 273:1855–1861 Pimenta W, Korytkowski M, Mitrakou A et al. (1995) Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerance individuals with a first degree NIDDM relative. JAMA 273:1855–1861
25.
go back to reference Larsson H, Ahren B (1996) Failure to adequately adapt to reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39:1099–1107CrossRefPubMed Larsson H, Ahren B (1996) Failure to adequately adapt to reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39:1099–1107CrossRefPubMed
26.
go back to reference Beck Nielsen H, Groop LC (1994) Metabolic and genetic characteristics of prediabetic states: sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714–1721PubMed Beck Nielsen H, Groop LC (1994) Metabolic and genetic characteristics of prediabetic states: sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714–1721PubMed
27.
go back to reference Ahren B, Taborsky GJ (2003) Beta-cell function and insulin secretion. In: Porte D, Sherwin RS, Baron A (eds) Ellenberg Rifkins diabetes mellitus. McGraw Hill, New York, pp 43–65 Ahren B, Taborsky GJ (2003) Beta-cell function and insulin secretion. In: Porte D, Sherwin RS, Baron A (eds) Ellenberg Rifkins diabetes mellitus. McGraw Hill, New York, pp 43–65
28.
go back to reference Fehmann HC, Goke R, Goke B (1995) Cell and molecular biology of the incretin hormones glucagons-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390–410PubMed Fehmann HC, Goke R, Goke B (1995) Cell and molecular biology of the incretin hormones glucagons-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390–410PubMed
29.
go back to reference Drucker DJ (1998) Glucagon-like peptides. Diabetes. 47:159–69 Drucker DJ (1998) Glucagon-like peptides. Diabetes. 47:159–69
30.
go back to reference The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197PubMed The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197PubMed
31.
go back to reference Frankenfield DC, Rowe WA, Cooney RN et al. (2001) Limits of body mass index to detect obesity and predict body composition. Nutrition 17:26–30CrossRefPubMed Frankenfield DC, Rowe WA, Cooney RN et al. (2001) Limits of body mass index to detect obesity and predict body composition. Nutrition 17:26–30CrossRefPubMed
32.
go back to reference Bonora E, Del Prato S, Bonadonna RC et al. (1992) Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 41:1151–1159PubMed Bonora E, Del Prato S, Bonadonna RC et al. (1992) Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 41:1151–1159PubMed
33.
go back to reference DeFronzo RA, Tobin JD, Andres R. (1979) The glucose clamp technique. A method for quantifying insulin secretion and resistance. Am J Physiol 6:E214–E223 DeFronzo RA, Tobin JD, Andres R. (1979) The glucose clamp technique. A method for quantifying insulin secretion and resistance. Am J Physiol 6:E214–E223
34.
go back to reference Groop LC, Bonadonna RC, Del Prato S et al. (1989) Effect of insulin on oxidative and non-oxidative pathways of glucose and FFA metabolism in NIDDM. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213PubMed Groop LC, Bonadonna RC, Del Prato S et al. (1989) Effect of insulin on oxidative and non-oxidative pathways of glucose and FFA metabolism in NIDDM. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213PubMed
35.
go back to reference Steele RW, Wall JS, DeBodo RC et al. (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15–24 Steele RW, Wall JS, DeBodo RC et al. (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15–24
36.
go back to reference DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMed DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMed
37.
go back to reference DeFronzo RA, Sherwin RS, Hendler R et al. (1978) Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 62:204–213PubMed DeFronzo RA, Sherwin RS, Hendler R et al. (1978) Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 62:204–213PubMed
38.
go back to reference Perley MJ, Kipnis DM (1967) Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. J Clin Invest 46:1954–62PubMed Perley MJ, Kipnis DM (1967) Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. J Clin Invest 46:1954–62PubMed
39.
go back to reference Buchanan TA, Xiang AH, Peters RK et al. (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51:2796–803PubMed Buchanan TA, Xiang AH, Peters RK et al. (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51:2796–803PubMed
40.
go back to reference Mitrakou A, Kelley D, Mokan M et al. (1992) Role of reduced suppression of glucose production and diminished, early insulin release in impaired glucose tolerance. N Engl J Med 326:22–29PubMed Mitrakou A, Kelley D, Mokan M et al. (1992) Role of reduced suppression of glucose production and diminished, early insulin release in impaired glucose tolerance. N Engl J Med 326:22–29PubMed
41.
go back to reference Chen K-W, Boyko EJ, Bergstrom RW et al. (1995) Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-year follow up of initially non-diabetic Japanese-American men. Diabetes Care 18:747–753PubMed Chen K-W, Boyko EJ, Bergstrom RW et al. (1995) Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-year follow up of initially non-diabetic Japanese-American men. Diabetes Care 18:747–753PubMed
42.
go back to reference Ahren B, Pacini G (1997) Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. Am J Physiol 273:E701–E710PubMed Ahren B, Pacini G (1997) Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. Am J Physiol 273:E701–E710PubMed
43.
go back to reference Cook JT, Page RC, Levy JC et al. (1993) Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function. Diabet Med 10:321–326PubMed Cook JT, Page RC, Levy JC et al. (1993) Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function. Diabet Med 10:321–326PubMed
44.
go back to reference Yalow RS, Benson SA (1960) Immonoassay of endogenous plasma insulin in man. J Clin Invest 39:1157–175 Yalow RS, Benson SA (1960) Immonoassay of endogenous plasma insulin in man. J Clin Invest 39:1157–175
45.
go back to reference Haffner SM, Miettinen H, Stern MP. (1996) Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes. J Clin Endocrinol Metab 81:1846–1851PubMed Haffner SM, Miettinen H, Stern MP. (1996) Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes. J Clin Endocrinol Metab 81:1846–1851PubMed
46.
go back to reference Lillioja S, Mott DM, Zawadzki JK et al. (1987) In vivo insulin action is familial characteristic in non-diabetic Pima Indians. Diabetes 36:1329–1335PubMed Lillioja S, Mott DM, Zawadzki JK et al. (1987) In vivo insulin action is familial characteristic in non-diabetic Pima Indians. Diabetes 36:1329–1335PubMed
47.
go back to reference Vaag A, Henriksen JE, Madsbad S et al. (1995) Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690–698PubMed Vaag A, Henriksen JE, Madsbad S et al. (1995) Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690–698PubMed
48.
go back to reference Gelding S, NithyananthanR, Chan S et al. (1994) Insulin sensitivity in non-diabetic relatives of patients with non-insulin-dependent diabetes from two ethnic groups. Clin Endocrinol 40:55–62 Gelding S, NithyananthanR, Chan S et al. (1994) Insulin sensitivity in non-diabetic relatives of patients with non-insulin-dependent diabetes from two ethnic groups. Clin Endocrinol 40:55–62
49.
go back to reference Caumo A, Vicini P, Zachwieja JJ et al. (1999) Undermodeling affects minimal model indexes: insights from a two-compartment model. Am J Physiol 276:E1171–E1193PubMed Caumo A, Vicini P, Zachwieja JJ et al. (1999) Undermodeling affects minimal model indexes: insights from a two-compartment model. Am J Physiol 276:E1171–E1193PubMed
50.
go back to reference Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man, measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man, measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed
51.
go back to reference Kieffer TJ, Habener JF (1999) The glucagon-like peptides. Endocr Rev 20:876–913PubMed Kieffer TJ, Habener JF (1999) The glucagon-like peptides. Endocr Rev 20:876–913PubMed
52.
go back to reference Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care-Rev 13:610–630 Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care-Rev 13:610–630
53.
go back to reference Leahy JL, Cooper HE, Werr GC (1987) Impaired insulin secretion associated with near normoglycemia. Diabetes 36:459–464PubMed Leahy JL, Cooper HE, Werr GC (1987) Impaired insulin secretion associated with near normoglycemia. Diabetes 36:459–464PubMed
54.
go back to reference Rossetti L, Shulman GI, Zawalich W et al. (1987) Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 80:1037–1044PubMed Rossetti L, Shulman GI, Zawalich W et al. (1987) Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 80:1037–1044PubMed
Metadata
Title
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
Authors
A. Gastaldelli
E. Ferrannini
Y. Miyazaki
M. Matsuda
R. A. DeFronzo, MD
Publication date
01-01-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 1/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1263-9

Other articles of this Issue 1/2004

Diabetologia 1/2004 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.